Physician profile
Catherine E Heider
NPI 1871084269
$517.94
in general payments reported to CMS, 2019-2025
11 companies · $33.04 in 2025
The $33.04 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $26.04 · 2022: $414 · 2024: $44.47 · 2025: $33.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $77.51.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $77.51 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $109.55 | 2022 | |
| Amgen INC. | $109.14 | 2022 | |
| Janssen Pharmaceuticals, INC | $95.43 | 2022 | |
| Boston Scientific Corporation | $33.04 | 2025 | Ranger, Ekosonic |
| Abbott Laboratories | $32.83 | 2022 | |
| Merck Sharp & Dohme LLC | $29.77 | 2021-2024 | Zerbaxa, Dificid |
| Purdue Pharma L.P. | $27.75 | 2024 | Nalmefene Hydrochloride |
| Lilly USA, LLC | $27.75 | 2021-2022 | |
| Hologic Sales and Service, LLC | $18.86 | 2022 | |
| Abbvie INC. | $17.18 | 2022 | |
| Phadia US INC. | $16.64 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Catherine Heider listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.